Food and Drug Administration

Dermatologic and Ophthalmic Drugs Advisory Committee

August 27, 2004


Pedgaptanib Sodium Injection (Macugen™), Eyetech Pharmaceuticals Pfizer, Inc. (HTM) (PPT)

Pegaptanib Benefit Risk Profile, Dr. Donald D'Amico, MD, Harvard Medical School (HTM) (PPT)

Eyetech Pharmaceuticals Back-Up Slides (HTM) (PPT)

Macugen (Pegaptanib Sodium Injection), Dr. Wiley Chambers, MD, FDA (HTM) (PPT)

Macugen (Pegaptanib Sodium Injection) - Overview, Dr. Jennifer Harris, MD, FDA (HTM) (PPT)

FDA Questions (HTM) (PPT)